Protective immunity towards intracellular pathogens.

Clinical Cooperation Group, Antigen Specific Immunotherapy, GSF, Institute of Health and Environment and Technical University of Munich, Germany.
Current Opinion in Immunology (Impact Factor: 7.87). 09/2006; 18(4):458-64. DOI: 10.1016/j.coi.2006.05.008
Source: PubMed

ABSTRACT Immunity towards intracellular pathogens is often dependent upon the generation of CD8(+) memory T cells, which provide long-lasting and effective protection. Over the past few years, we have gained novel insights into the heterogeneity of CD8(+) T cells, time points of lineage commitment, and lineage relationships between subpopulations. These studies suggest that memory CD8(+) T cells progressively develop from naïve cells early during the immune response and further differentiate unidirectionally into short-living effector cells. We have also learnt that different memory subsets play distinct roles in conferring protection: whereas effector memory T cells are able to provide immediate protection but are not necessarily maintained long-term, central memory T cells have the potential for constant self-renewal. Thus, neither subset really fulfills all criteria of memory. As protective effector memory cells can develop from central memory cells, vaccination strategies should focus on induction of a balanced ratio of the two memory T cell subsets.